Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
Sarepta investigating mistakenly submitted Duchenne therapy report
The report showed that two weeks after receiving the therapy, the patient in question presented with symptoms of dark coloured urine and elevated creatine phosphokinase levels, which could be attributed to
Latest news
-
Hancock trumpets £250m fund for AI in the health service
I want our AI lab to generate cutting-edge technology to diagnose illnesses like sepsis, stroke and heart attacks before symptoms appear,” he added.
-
AbbVie files blockbuster hopeful elagolix for uterine fibroids
night sweats, despite the use of a so-called ‘add-back’ therapy with hormone drugs to minimise those symptoms. ... That raises the question of whether women will be prepared to tolerate the menopausal side effects in order to tackle the relatively
-
Boris pledges a £1.8bn cash injection for the NHS
One symptom of that is that the NHS has been unable to meet its 62-day target for cancer treatment for the past five years, partly due to a lack of
-
CHMP backs Bayer’s tumour-agnostic drug Vitrakvi
There were two other positive opinions on new medicines at the CHMP meeting last week, with the panel backing Acorda Therapeutics’ inhaled Inbrija (levodopa) for the treatment of symptoms of ‘off’
-
Myovant has second phase 3 trial to back its uterine fibroids drug
In many cases they cause no symptoms, but around a quarter of women experience pain, abnormal bleeding and other symptoms, and may experience fertility problems. ... The data from the two pivotal LIBERTY studies suggest we have a medicine that could
More from news
Approximately 2 fully matching, plus 1,078 partially matching documents found.
Latest Intelligence
-
AI’s role in pharma marketing
in key branded messages that also help them test their knowledge on treating common symptoms that our client’s brand addresses.
-
Streamlining clinical trials – why better data use is key
Gen Li from Phesi commented that “challenges in patient recruitment are only the symptom of underlying clinical trial dysfunction”, citing the inability to find successful investigators and the lack of effective
-
25 Women Leaders in UK Healthcare
A chatbot poses questions to the users and helps them to understand their symptoms, suggesting what a condition might be and how to seek further help.
-
Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019
of JAK proteins is an established method of controlling the symptoms of this disease.
-
Where next in Alzheimer’s disease R&D?
While M1 agonists only treat the symptoms of Alzheimer’s, rather than slow or stop the progression of the disease, the efficacy seen in the 1990s was tantalising enough to spur
More from intelligence
Approximately 0 fully matching, plus 91 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
The relevance of patient perspectives to value
Patient insights also are needed to justify treatment claims for improving symptoms or quality of life.
-
Porphyria Awareness Week – Round Up
Symptoms are broad and can vary dramatically in severity, often leaving doctors mystified whilst patients suffer.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
2) The child may display a variety of different symptoms which do not match one disorder and a clear diagnosis is not reached. ... 3) The child might have an array of symptoms that are in fact an unusual presentation of a known rare condition.
-
Diagnosing the lag in neuropsychiatric treatments
Another consequence of the unknown pathophysiology of neuropsychiatric diseases is the ‘shotgun approach’ in treatment measures, in which doctors look at the symptoms rather that the root cause of the disease. ... Instead, they prescribe a medicine
-
The role of brain health in treating MS
Relapses cause brain volume shrinkage, which is thought to lead to the symptoms of MS. ... doctors easier access to symptoms and results.
More from PMHub
Approximately 0 fully matching, plus 106 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
BASTARD . LONDON
BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
